Search results
The Novartis “Managed Access” terminology covers all locally defined pre-approval access mechanisms and programs such as “Compassionate Use”, “Expanded Access”, “Named Patient Supply”, “Special Access Schemes/Programs”, “Autorisations temporaires d’utilisation (ATU)” and others.
- PDF
PDF - Managed access programs | Novartis
- AVXS-101 Managed Access Program
AVXS-101 Managed Access Program. Feb 05, 2020. We are aware...
- PDF
The Novartis Gene Therapies global Managed Access Program (MAP) is designed to provide a potential pathway for patients seeking such a treatment, provided the required eligibility criteria are met and in accordance with applicable local laws and regulations.
Novartis Oncology Access (NOA) is a sustainable access solution which is designed to improve access to cancer medicines in countries with very limited healthcare reimbursement systems. Compassionate use: Providing access to much needed treatments.
Jan 9, 2023 · Since it first launched, we have worked to broaden global access to Zolgensma® (onasemnogene abeparvovec), closely collaborating with local governments and payors to craft innovative access solutions that enable eligible spinal muscular atrophy (SMA) patients to obtain the gene therapy.
Dec 19, 2019 · AVXS-101 Managed Access Program. Feb 05, 2020. We are aware of the recent Ministry of Health (MoH) announcement, that five EU states (Belgium, the Netherlands, Luxembourg, Austria and Ireland) have issued a joint statement regarding our Global Managed Access Program (MAP).
Jan 24, 2022 · Today, we are proud to announce we have renewed the global MAP program with up to 100 doses again planned in 2022. This program benefits patients and families who otherwise would not have access to our gene therapy or other SMA treatments and is a particular point of pride for our organization.
The Novartis Gene Therapies “Managed Access Program” terminology covers all locally defined pre-approval access mechanisms and programs such as “Compassionate Use”, “Expanded Access”, “Named Patient Supply”, “Special Access Schemes/Programs”, “Autorisations temporaires d’utilisation (ATU)” and others.
